Atrion Corp represents values of integrity, innovation, and excellence. With a strong corporate philosophy focused on delivering high-quality products and services, Atrion Corp aims to meet the evolving needs of its customers and enhance their lives. The company emphasizes a culture of continuous improvement, fostering a collaborative environment that encourages teamwork and empowers its employees to drive growth. By prioritizing customer satisfaction and maintaining a commitment to ethical business practices, Atrion Corp demonstrates its dedication to long-term success and sustainable growth in the competitive market.

Atrion Corp is primarily present in the United States.

Atrion Corp has achieved several significant milestones throughout its history. The company has consistently displayed strong financial performance, with consistent revenue growth year after year. Atrion is renowned for its innovation and product development, constantly introducing groundbreaking solutions in the healthcare industry. The company has also successfully expanded its global presence, reaching out to various countries and establishing strategic partnerships. Atrion's commitment to customer satisfaction and quality has earned them numerous accolades and awards. With a strong track record of success, Atrion Corp continues to lead and excel in the market, solidifying its position as a top player in the industry.

Atrion Corp, established in 1944, is a leading manufacturer of medical devices and components. The company has a rich history of delivering innovative solutions across various industries. Founded initially as a fabric and rubber company, Atrion Corp transitioned to medical devices in the 1960s. They specialize in the development and production of cardiovascular, ophthalmic, and fluid delivery products that enhance patient care. With a strong commitment to quality and customer satisfaction, Atrion Corp has become a trusted name in the healthcare industry. Their consistent growth and dedication to excellence have solidified their position as a reliable and reputable company.

The main competitors of Atrion Corp in the market include companies such as Johnson & Johnson, Abbott Laboratories, Becton, Dickinson and Company, and Thermo Fisher Scientific. These companies operate in similar sectors as Atrion Corp, giving them a notable presence in the market. However, Atrion Corp differentiates itself by offering innovative products and solutions tailored to specific medical needs, which helps maintain its competitive edge in the industry. With its strong market position and commitment to excellence, Atrion Corp strives to stay ahead of its competitors and deliver value to its stakeholders.

Atrion Corp is primarily active in the healthcare and medical device industries.

Atrion Corp operates as a leading medical device manufacturer, specializing in providing innovative products and solutions to the healthcare industry. The company focuses on developing and commercializing medical devices primarily for cardiovascular, ophthalmic, and fluid delivery applications. With a strong emphasis on research and development, Atrion Corp aims to enhance patient care by offering high-quality and technically advanced products. By leveraging its expertise in medical technologies, Atrion Corp strives to contribute to advancements in healthcare and improve medical outcomes globally.

KGV kan i øjeblikket ikke beregnes for Atrion.

KUV kan i øjeblikket ikke beregnes for Atrion.

AlleAktien Kvalitetsscore for Atrion er 3/10.

Omsætningen kan i øjeblikket ikke beregnes for Atrion.

Overskuddet kan i øjeblikket ikke beregnes for Atrion.

Atrion Corporation is a global company specializing in the development, manufacturing, and distribution of medical devices and components. The company is headquartered in Allen, Texas and operates production facilities in the USA and Europe. Atrion has become a major player in the medical technology industry in recent decades. The company serves various markets including cardiology, surgery, neurology, and dermatology specialties. Atrion also offers a range of services including customization of products for specific customer requirements and support in the clinical development of medical devices. The company is committed to providing quality products that are safe and effective for both doctors and patients. Atrion's business model is based on several pillars: 1. Manufacturing of medical components: Atrion produces a wide range of medical components including catheters, tubes, rubber stoppers, and implants. These components are purchased by other medical technology companies and integrated into their own products. The high quality of Atrion's components has contributed to the company's strong market position. 2. Sale of proprietary products: Atrion has also developed and sells a number of its own medical devices including detectable wound closure agents and injection devices. These products help promote the company's growth and reduce dependence on the manufacturing of components. 3. Customization of products: Atrion offers customized customization of products to meet specific customer needs. This allows customers to receive products that meet their requirements, leading to higher customer satisfaction. 4. Support in clinical development: Atrion also provides support in the clinical development of medical devices. The company works closely with customers to help develop products that meet FDA requirements and enable successful market entry. Atrion has expanded its portfolio in recent years. In 2017, the company acquired Dutch firm DSM Biomedical BV from Royal DSM. DSM Biomedical is a leading provider of medical coatings and materials, and this acquisition has allowed Atrion to venture into new areas of medical technology. Overall, Atrion has built a solid business model and a strong market position. By providing quality products and focusing on customer needs, the company has built a loyal customer base and successfully diversified its business. Atrion continues to focus on growth and innovation to solidify its position as a leading provider of medical devices and components.

Atrion udbetaler et udbytte på 8,20 USD fordelt over 4 udbetalinger om året.

Atrion udbetaler 4 gange om året en udbytte.

ISIN'en for Atrion er US0499041053.

WKN for Atrion er 922778.

Tickeren for Atrion er ATRI.

I løbet af de sidste 12 måneder betalte Atrion en dividende på 8,70 USD . Dette svarer til et dividendeudbytte på omkring 1,92 %. For de kommende 12 måneder vil Atrion sandsynligvis betale en dividende på 8,70 USD.

Udbytteafkastet for Atrion er i øjeblikket 1,92 %.

Atrion betaler kvartalsvis udbytte. Dette uddeles i månederne oktober, december, april, juli.

Atrion betalte udbytte hvert år i løbet af de sidste 20 år.

For de kommende 12 måneder forventes der dividender på 8,70 USD. Dette svarer til et dividendeafkast på 1,91 %.

Atrion bliver tildelt sektoren 'Sundhed'.

For at modtage det seneste udbytte på Atrion fra den 28.6.2024 på 2,2 USD, skulle du have haft aktien i din portefølje før ex-datoen den 14.6.2024.

Udbetalingen af det sidste udbytte blev foretaget den 28.6.2024.

I løbet af 2023 udbetalte Atrion 8,2 USD i form af dividender.

Udbytterne fra Atrion udbetales i USD.